Klaus Herfarth
Has participated in:
-
Die Physiologie und Pathophysiologie der Sekretion von intaktem Parathormon
-
Treatment of limited stage follicular lymphoma with Rituximab immunotherapy and involved field radiotherapy in a prospective multicenter Phase II trial-MIR trial
-
Management of organ motion in scanned ion beam therapy
-
Management of organ motion in scanned ion beam therapy